Trial Profile
A Long-Term Observational Cohort Study of HIV Infection in Participants Who Seroconvert After Enrolment in Dapivirine Vaginal Ring Trials
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 05 Sep 2019 Status changed from recruiting to completed.
- 27 Mar 2018 Planned number of patients changed from 68 to 150.
- 27 Mar 2018 Planned End Date changed from 1 Dec 2015 to 1 Jul 2019.